Ginkgetin mediates ferroptosis in NSCLC through mechanisms such as increasing iron in concentration, promoting lipid peroxidation, inhibiting SLC7A11 and GPX4 expression, and decreasing the GSH/GSSG ratio. This evidence concerns the gene GPX4 and non-small cell lung carcinoma.